Allogene Therapeutics, Inc. (ALLO) Technical Analysis

🔺 Technical Setup

📊 Technical Summary

Allogene Therapeutics, Inc. (ALLO) finished the session at 2.39 (+0.84%). Broadly speaking, trend structure still looks constructive because price remains above both the 50-day and 200-day averages. 20-day momentum is positive at +7.66%, with price remains inside its roughly 52-week range (0.95–3.06), while ATR14 volatility is elevated at roughly 16.56% of price. RSI(14) is 48.9, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. From a pattern perspective, the main active signal is Cup & handle. Initial downside support sits near 2.29. Holding that area would help preserve the current chart structure. On the fundamentals side, the latest snapshot shows Net income: -41.40M · EPS (basic): -0.19. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more